Emerging risks | Growth Opportunities | APAC Insurance

Thursday, November 5, 2026

Retrospective solutions gain traction, but APAC adoption lags

Across APAC, legal fragmentation and lingering misconceptions continue to limit the use of retrospective solutions, SIRC panellists said.
Colored puzzle pieces with coins arranged on a wooden table, with a hand holding one green piece.
November 5, 2026

 • 

7 min read
(Re)in AsiaSIRC 2026 Hub(Re)in AsiaSIRC 2026HubExplore the hub →

(Re)in Summary

  • Retrospective solutions such as loss portfolio transfers (LPTs) and adverse development covers (ADCs) are increasingly used for capital management, not only to clear distressed portfolios.
  • PwC recorded 42 publicly announced non-life run-off deals in 2025, transferring an estimated US$5.4bn in liabilities.
  • An LPT delivers near-immediate capital relief, while relief from a quota share builds over time.
  • In M&A, LPTs can widen the buyer pool and avoid discounts on disputed legacy liabilities.
  • Early engagement with rating agencies and regulators helps avoid post-deal surprises and approval delays.
  • Stigma, fragmented markets, local domicile rules and short-tail liabilities limit adoption across APAC outside Australia.

Retrospective reinsurance is becoming a routine capital management tool for insurers around the world, but uptake in APAC remains limited, as diverse legal frameworks and structural limits hamper potential growth, said panellists at the Singapore International Reinsurance Conference (SIRC) on Wednesday (4 November).

Insurers are increasingly turning to retrospective solutions like loss portfolio transfers (LPTs) and adverse development covers (ADCs) to pass the economic risk of claims that have been incurred to a reinsurer, releasing capital held against reserves.

LPTs move an agreed portfolio of existing claims reserves to a reinsurer, which takes on the associated economic risk. ADCs leave reserves and claims handling with the insurer, which buys protection against claims exceeding an agreed attachment point. Some deals also have legal finality, transferring the liabilities through portfolio transfers or schemes to another (re)insurer.

Under risk-based capital regimes now operating across much of Asia-Pacific, claim liabilities typically form the largest component of required capital, said Roshan Perera, CEO APAC at Gallagher Re. “It’s not capital in the traditional sense, but it’s about unlocking that capital.”

A total of 42 publicly announced non-life run-off insurance transactions were observed in 2025, according to data by PwC, with about US$5.4bn in estimated liabilities transferred.

Large, established insurance groups, not just run-off or distressed carriers, now account for much of that activity, said Timothy Chan, special counsel for insurance in APAC for Norton Rose Fulbright and committee member for the Insurance and Reinsurance Legacy Association (IRLA), which sponsored the session.

“The market is no longer simply about cleaning up the past; it’s increasingly about creating capacity and flexibility for the future.”

This shift is a sign that retrospective solutions are going to be “a normal part” of how an insurer can manage its capital, Chan said.

The ideal add-on for M&As

Mergers and acquisitions are a key setting for these deals. Buyers and sellers use retrospective solutions to separate historical liabilities from the ongoing business, which “can make an acquisition or disposal cleaner, easier to execute, and perhaps even more attractive,” Chan said.

In a sale, an LPT can improve value, speed and certainty, said Russell Kueh, executive director of APAC insurance investment banking at J.P. Morgan. Where buyers disagree with the seller on the value of a legacy book, it can widen the pool of bidders and avoid a discount, while sparing both sides prolonged negotiation over those liabilities. “A solution like LPT allows both sides to have more certainty as to the finality of this piece of historical liability.”

For Ashish Hathi, chief risk and compliance officer at HSBC Life, the decision to seek a retrospective solution starts with strategy and risk appetite. After an acquisition or strategic repositioning, an insurer may hold liabilities it no longer considers core, he said.

“Quite often, you’ll find that through M&A, you acquire portfolios that maybe you don’t have the best expertise to manage,” Hathi said. The buyer may lack the claims capability or operational fit to run off those books efficiently.

Management bandwidth is another factor. “Typically management teams want to focus on what is strategically important going forward,” he said.

An LPT will deliver “almost a day one capital benefit” that then tails off, unlike a quota share, where relief builds over time, said Alison Drill, head of P&C structured solutions APAC at Swiss Re.

Despite only two of the 42 publicly announced run-off transactions occurring in Asia, Drill said a number of additional transactions take place privately across the region.

“It can be looking to free up capital for a particular purpose, such as an acquisition,” she said. “It may also be a motivation that there is a particular area of concern in those reserves.”

In APAC, RiverStone International inked a legacy portfolio transaction with Zurich Australia covering professional indemnity, general liability and workers’ compensation in March. Subsequently, QBE Insurance Group entered into reinsurance arrangements covering around US$1.6bn of long-tail reserves in August.

“We’re seeing transactions being linked to M&A, strategic pivots, exits of non-core business, and increasingly capital and portfolio optimisation,” said Chan.

The case for retrospective deals has held even as the market softens, said panellists. Higher interest rates lift investment income on reserves, and softer pricing removes the pressure insurers face in a hard market, Perera said.

But reserve risks remain the largest consumer of capital under the region’s risk-based frameworks, Perera added. “People are starting to use these types of products more strategically as a capital management tool,” he said. “It’s increasingly becoming part of the CFO’s toolkit.”

Investors have responded positively to some transactions. Chan noted that IAG’s share price rose 7% on the day it announced an ADC with Enstar in 2024 alongside a five-year natural perils cover and reaffirmed guidance.

For listed insurers, success depends on presenting “a very clear and simple, measurable story”, Kueh said. Sellers should focus on the financial impact, while buyers need a compelling “strategic narrative”.

Perera said rating agencies typically assess the rationale for the transaction and whether it strengthens balance-sheet resilience. “[Agencies] would most likely be positive, because you’re responding to a motivation that should make the value chain stronger.”

Kueh, meanwhile, recommended engaging rating agencies early to avoid surprises around post-transaction outcomes. Drill added that insurers should also involve regulators early, particularly in legal-finality transfers, where regulators are ultimately the key decision-makers.

Retro perceptions

Despite their utility and rising popularity, retrospective solutions still carry a stigma.

“People are concerned about this perception that you’re not running your business properly,” said Perera. “I had a conversation with a CEO client who was looking at capital management, and when I suggested this, he was saying, ‘What are you saying about my business?’”

“We need to move beyond that perception that these transactions only happen in relation to distressed portfolios,” Perera said.

The region’s fragmented markets pose further barriers. In cases where deals carry legal finality, “it’s a jurisdiction or domicile by domicile case,” said Drill.

In Hong Kong, the regulator expects a transfer of a back book to go to another locally domiciled entity, and “that can be a restriction”, Drill said. Many Asian liabilities are also short-tail, reducing the value of such cover.

“So the fragmentation of that doesn’t naturally lend itself to these very large deals.”

Outside Australia, LPTs rarely feature in Asian insurer M&A deals, said Kueh. Licensing usually keeps life and P&C businesses in separate entities, and large P&C acquisitions have been rare in Asia. In smaller sales, a seller may decide it is simpler to accept a lower price than add an LPT. “It’s just not a lot at stake in terms of dollars.”

But advisers should raise them as options at the C-suite level, Kueh said. “At least, if the final decision is not to go for LPT or ADC, it’s a very deliberate one, after considering all the facts.”

Boards need a better understanding of retrospective solutions, Hathi said.

“It’s not a way to hide something,” he said. “It’s a genuine capital management tool that can be used effectively in the right scenario.”

(Re)in AsiaSIRC 2026 Hub(Re)in AsiaSIRC 2026HubExplore the hub →